| Print
Codexis (CDXS)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
Address
200 Penobscot Drive
Redwood City
CA
USA
94063
Telephone
+1 650 421-8100
Forecast key dates
Name | Key Date |
---|---|
Codexis Inc Fourth Quarter Earnings Conference Call for 2025 | 2026-02-27T16:30:00 |
Codexis Inc Fourth Quarter Earnings Results for 2025 | 2026-02-27T00:00:00 |
Codexis Inc Annual Report for 2025 | 2026-02-27T00:00:00 |
Codexis Inc Third Quarter Earnings Conference Call for 2025 | 2025-10-31T16:30:00 |
Codexis Inc Third Quarter Earnings Results for 2025 | 2025-10-31T00:00:00 |
Codexis Inc Second Quarter Earnings Conference Call for 2025 | 2025-08-08T16:30:00 |
Codexis Inc Second Quarter Earnings Results for 2025 | 2025-08-08T00:00:00 |
Codexis Inc Annual General Meeting for 2025 | 2025-06-11T16:00:00 |
Codexis Inc First Quarter Earnings Conference Call for 2025 | 2025-05-02T16:30:00 |
Codexis Inc First Quarter Earnings Results for 2025 | 2025-05-02T00:00:00 |
Previous key dates
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.